Purpose: Until now, there have been almost no published references that focus on the postoperative results of patients with complicated primary small bowel lymphoma (PSBL). Our goal is to analyze the postoperative results of patients who underwent emergency surgery for PSBL. Methods: Retrospective observational study of patients diagnosed with complicated PSBL who underwent emergency surgery between 2016 and 2024. The presented gastrointestinal symptoms or findings in the imaging tests that showed hemorrhage, obstruction, or perforation. The incidence of postoperative complications, as well as total (TS) and disease-free survival (DFS) after surgery, were evaluated. Results: Seventeen patients with the diagnosis of PSBL were analyzed. The most common clinical manifestation was intestinal obstruction (41.2%). The most frequent location was the ileum (47%). 40% of patients were diagnosed with diffuse large B-cell lymphoma (41.2%). In total, 12 patients (70.7%) had Lugano stage I disease. The mean TS of the patients was 39 months (range: 32–46). The TS of the patients with B-cell lymphoma was higher than T-cell lymphoma (B-cell lymphoma 27 months vs. T-cell lymphoma 8 months, P = 0.018). The median DFS was 41 months (range: 33–49). The DFS of patients with B-cell lymphoma was higher than T-cell lymphoma (27 months vs. 6 months. P = 0.019). Conclusions: Emergency surgery due to complications in patients with primary intestinal lymphoma does not have negative predictive value on their survival. The prognosis is worse in patients with T-cell primary intestinal lymphomas with a higher rate of postoperative complications and recurrence.

Objectives: Gastric cancer is one of the leading causes of cancer-related mortality. Sarcopenia, characterized by reduced skeletal muscle mass, strength, and physical performance, is associated with poorer outcomes in gastrointestinal cancers. This study aimed to evaluate the prevalence of sarcopenia, including the Total Psoas Area Index (TPAI), and its association with tumor stage, postoperative complications, and survival in patients with gastric adenocarcinoma. Methods: A retrospective study was conducted, including 79 patients who underwent surgery for gastric adenocarcinoma. Sarcopenia was assessed using a combination of CT-derived muscle mass (TPAI), muscle strength (dynamometry), and functional status (SARC-F). Patients were divided into sarcopenic (SG) and non-sarcopenic (NSG) groups. Clinical and survival data were compared between groups. Results: Sarcopenia was identified in 36.7% of patients. Early-stage disease (I–II) was less frequent in the SG (20.7%) compared to the NSG (44%), whereas stage IV tumors were more common in the SG (20.7% vs. 6%). Sarcopenic patients had a lower body mass index and underwent fewer laparoscopic procedures (44.8% vs. 68%, p = 0.03). Postoperative complications, such as pneumonia and ileus, were more frequent in the SG. Overall survival was significantly lower in the SG (17 vs. 21 months, respectively, p = 0.042), with a reduction in disease-free survival as well. Postoperative TPAI values remained lower in the SG. Conclusions: Sarcopenia, as defined by combined assessment including TPAI, was associated with advanced tumor stage, increased postoperative risk, and reduced survival in patients with gastric cancer. Preoperative assessment of muscle mass may help identify high-risk patients and optimize clinical management.

We present the case of a patient with an unusual finding of gastric anthracosis during oncological surgery for gastric adenocarcinoma.